CereLink ICP Extension Cable (Extension Cable), Model No. 826845 Used with Codman CereLink Int...

FDA Device Recall #Z-0548-2024 — Class I — October 5, 2023

Recall Summary

Recall Number Z-0548-2024
Classification Class I — Serious risk
Date Initiated October 5, 2023
Status Ongoing
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Integra LifeSciences Corp.
Location Princeton, NJ
Product Type Devices
Quantity 4941

Product Description

CereLink ICP Extension Cable (Extension Cable), Model No. 826845 Used with Codman CereLink Intracranial Pressure (ICP) Monitor, Model No. 826820/826820P. Cable is also provided with monitor as part of the same SKU.

Reason for Recall

Firm is expanding the existing recall RES 90457 for the Cerelink, initiated in June 2022, to include all CereLink ICP Extension Cables. The updated corrective action includes a design change to the extension cable to address the "out of range readings" issue.

Distribution Pattern

US distribution nationwide to the following states: AL AR AZ CA CO CT DC DE FL GA IA KY LA MA ME MN ND NE NH NJ NY OK PA RI TN TX UT VA WI WV OUS distribution to Australia/New Zealand, Canada, and Europe/Middle East/Africa.

Lot / Code Information

UDI-DI 10381780520665 All lots distributed

Other Recalls from Integra LifeSciences Corp.

Recall # Classification Product Date
Z-1295-2025 Class II AURORA Surgiscope System, Sterile, single use d... Feb 6, 2025
Z-1168-2025 Class II Brand Name: MediHoney¿ Gel Product Name: MediH... Jan 10, 2025
Z-0977-2025 Class II CODMAN CERTAS Plus Programmable Valve Inline Sm... Dec 16, 2024
Z-0978-2025 Class II CODMAN CERTAS Plus Programmable Valve Inline Sm... Dec 16, 2024
Z-0979-2025 Class II CODMAN CERTAS Plus Programmable Valve Right Ang... Dec 16, 2024

Frequently Asked Questions

Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.

Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.

Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.

What Should You Do?

Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.